(Q39925358)

15 September 2017

title

Therapeutic effect of intratracheal administration of murine IL-4 receptor antagonist on asthmatic airway inflammation (English)

1 reference

15 September 2017

0 references

0 references

Daiyin Tian

1

1 reference

15 September 2017

Zhou Fu

2

1 reference

15 September 2017

Enmei Liu

3

1 reference

15 September 2017

Yunfeng He

4

1 reference

15 September 2017

Xiaofang Wang

5

1 reference

15 September 2017

Lijia Wang

6

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

45

1 reference

15 September 2017

issue

8

1 reference

15 September 2017

page(s)

715-721

1 reference

Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

21 January 2018

IL-13 effector functions

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

IL-4 induces IL-13-independent allergic airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

Persistent effects induced by IL-13 in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

The IL-4 receptor: signaling mechanisms and biologic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

The role of IL-13 and its receptor in allergy and inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

A single administration of interleukin-4 antagonistic mutant DNA inhibits allergic airway inflammation in a mouse model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

Tryptase inhibition blocks airway inflammation in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

Controlling chemical reactivity with antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

STAT6 is required for the anti-inflammatory activity of interleukin-4 in mouse peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

Distribution and cytokine production of CD4 and CD8 T-lymphocyte subsets in patients with acute asthma attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

Alterations in T-lymphocyte subsets in the airways of asthmatic patients with active hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802252085

10.1080/02770900802252085

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference